Soya isoflavone consumption in relation to carotid intima-media thickness in Chinese equol excretors aged 40-65 years

British Journal of Nutrition

Volumn 108, Issue 9, 2012, Pages 1698-1704

  Cai, Yun ^a   Guo, Kaiping ^a   Chen, Chaogang ^b   Wang, Ping ^a   Zhang, Bo ^a   Zhou, Quan ^a   Mei, Fang ^a   Su, Yixiang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Blood lipids; Carotid artery intima media thickness; Equol; Isoflavones

Indexed keywords

DAIDZEIN; EQUOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOFLAVONE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; COMMON CAROTID ARTERY; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; HUMAN; MALE; MIDDLE AGED; SOYBEAN; TRIACYLGLYCEROL BLOOD LEVEL; URINALYSIS; URINARY EXCRETION;

ADULT; AGED; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; CHINA; DIET; EQUOL; FEMALE; HUMANS; ISOFLAVONES; LIPIDS; MALE; MIDDLE AGED; PHYTOESTROGENS; QUESTIONNAIRES; RISK FACTORS; SEEDS; SOYBEANS;

EID: 84870013069     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511007331     Document Type: Article

References (29)

1. Setchell KD (1998) Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 68, 1333S-1346S.
2. Setchell KD, Clerici C, Lephart ED, et al. (2005) S-Equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am J Clin Nutr 81, 1072-1079.
3. Lichtenstein AH (1998) Soy protein, isoflavones and cardiovascular disease risk. J Nutr 128, 1589-1592.
4. Zhang X, Shu XO, Gao YT, et al. (2003) Soy food consumption is associated with lower risk of coronary heart disease in Chinese women. J Nutr 133, 2874-2878.
5. Zhan S & Ho SC (2005) Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr 81, 397-408.
6. Reynolds K, Chin A, Lees KA, et al. (2006) A meta-analysis of the effect of soy protein supplementation on serum lipids. Am J Cardiol 98, 633-640.
7. Sacks FM, Lichtenstein A, Van Horn L, et al. (2006) Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 113, 1034-1044.
8. Weggemans RM & Trautwein EA (2003) Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans: a meta-analysis. Eur J Clin Nutr 57, 940-946.
9. Watanabe S, Yamaguchi M, Sobue T, et al. (1998) Pharmaco-kinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60g baked soybean powder (kinako). J Nutr 128, 1710-1715.
10. Song KB, Atkinson C, Frankenfeld CL, et al. (2006) Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls. J Nutr 136, 1347-1351.
11. Karr SC, Lampe JW, Hutchins AM, et al. (1997) Urinary isofla-vonoid excretion in humans is dose dependent at low to moderate levels of soy-protein consumption. Am J Clin Nutr 66, 46-51.
12. Guo K, Zhang B, Chen C, et al. (2010) Daidzein-metabolising phenotypes in relation to serum lipids and uric acid in adults in Guangzhou, China. Br J Nutr 104, 118-124.
13. Franke A, Morimoto Y, Yeh L, et al. (2006) Urinary isoflavo-noids as a dietary compliance measure among premenopau-sal women. Asia Pac J Clin Nutr 15, 88-94.
14. Tseng M, Olufade T, Kurzer MS, et al. (2008) Food frequency questionnaires and overnight urines are valid indicators of daidzein and genistein intake in U.S. women relative to multiple 24-h urine samples. Nutr Cancer 60, 619-626.
15. Setchell KD & Cole SJ (2006) Method of defining equol-producer status and its frequency among vegetarians. J Nutr 136, 2188-2193.
16. Liu B, Qin L, Liu A, et al. (2010) Prevalence of the equol-producer phenotype and its relationship with dietary isoflavone and serum lipids in healthy Chinese adults. J Epidemiol 20, 377-384.
17. Arai Y, Uehara M, Sato Y, et al. (2000) Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J Epidemiol 10, 127-135.
18. Setchell KD & Cassidy A (1999) Dietary isoflavones: biological effects and relevance to human health. J Nutr 129, 758S-767S.
19. Frankenfeld CL, Atkinson C, Thomas WK, et al. (2005) High concordance of daidzein-metabolizing phenotypes in individuals measured 1 to 3 years apart. Br J Nutr 94, 873-876.
20. Lampe JW, Skor HE, Li S, et al. (2001) Wheat bran and soy protein feeding do not alter urinary excretion of the isofla-van equol in premenopausal women. J Nutr 131, 740-744.
21. Vedrine N, Mathey J, Morand C, et al. (2006) One-month exposure to soy isoflavones did not induce the ability to produce equol in postmenopausal women. Eur J Clin Nutr 60, 1039-1045.
22. O'Leary DH, Polak JF, Kronmal RA, et al. (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340, 14-22.
23. Hollander M, Hak AE, Koudstaal PJ, et al. (2003) Comparison between measures of atherosclerosis and risk of stroke: the Rotterdam Study. Stroke 34, 2367-2372.
24. Zhang B, Chen YM, Huang LL, et al. (2008) Greater habitual soyfood consumption is associated with decreased carotid intima-media thickness and better plasma lipids in Chinese middle-aged adults. Atherosclerosis 198, 403-411.
25. Nagata C, Takatsuka N & Shimizu H (2002) Soy and fish oil intake and mortality in a Japanese community. Am J Epidemiol 156, 824-831.
26. Kokubo Y, Iso H, Ishihara J, et al. (2007) Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations-The Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation 116, 2553-2562.
27. Ricketts ML, Moore DD, Banz WJ, et al. (2005) Molecular mechanisms of action of the soy isoflavones includes activation of promiscuous nuclear receptors. A review. J Nutr Biochem 16, 321-330.
28. Hwang J, Wang J, Morazzoni P, et al. (2003) The phytoestro-gen equol increases nitric oxide availability by inhibiting superoxide production: an antioxidant mechanism for cellmediated LDL modification. Free Radic Biol Med 34, 1271-1282.
29. Meyer BJ, Larkin TA, Owen AJ, et al. (2004) Limited lipid-lowering effects of regular consumption of whole soybean foods. Ann Nutr Metab 48, 67-78.